ATE288587T1 - Verfahren zur bestimmung der lipid-aufnahme - Google Patents

Verfahren zur bestimmung der lipid-aufnahme

Info

Publication number
ATE288587T1
ATE288587T1 AT01938489T AT01938489T ATE288587T1 AT E288587 T1 ATE288587 T1 AT E288587T1 AT 01938489 T AT01938489 T AT 01938489T AT 01938489 T AT01938489 T AT 01938489T AT E288587 T1 ATE288587 T1 AT E288587T1
Authority
AT
Austria
Prior art keywords
lipid uptake
determining lipid
determining
uptake
elegans
Prior art date
Application number
AT01938489T
Other languages
English (en)
Inventor
Philippe Verwaerde
Cindy Anthonissen
Benoit Deprez
Beatrice Bonnet
Thierry Bogaert
Original Assignee
Devgen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devgen Nv filed Critical Devgen Nv
Application granted granted Critical
Publication of ATE288587T1 publication Critical patent/ATE288587T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
    • G01N2333/43534—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01938489T 2000-05-19 2001-05-21 Verfahren zur bestimmung der lipid-aufnahme ATE288587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012229.1A GB0012229D0 (en) 2000-05-19 2000-05-19 Lipid uptake assays
PCT/IB2001/001061 WO2001088533A2 (en) 2000-05-19 2001-05-21 Lipid uptake assays

Publications (1)

Publication Number Publication Date
ATE288587T1 true ATE288587T1 (de) 2005-02-15

Family

ID=9891997

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01938489T ATE288587T1 (de) 2000-05-19 2001-05-21 Verfahren zur bestimmung der lipid-aufnahme

Country Status (8)

Country Link
US (1) US6703214B2 (de)
EP (2) EP1282816A2 (de)
JP (2) JP2004524803A (de)
AT (1) ATE288587T1 (de)
AU (2) AU2001262601A1 (de)
DE (1) DE60108746T2 (de)
GB (2) GB0012229D0 (de)
WO (2) WO2001088532A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002031202A2 (en) * 2000-10-10 2002-04-18 Thomas Jefferson University High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds
WO2003100094A2 (en) * 2002-05-23 2003-12-04 Devgen Nv Method for determining the influence of a compound on cholesterol transport
WO2004033654A2 (en) * 2002-10-09 2004-04-22 Buck Institute Automated method for high throughput screening of nematodes
WO2006065709A2 (en) * 2004-12-15 2006-06-22 Schering Corporation Functional assays for cholesterol absorption inhibitors
US20100143937A1 (en) * 2007-05-31 2010-06-10 Sanofi-Aventis ASSAY METHODS FOR IDENTIFYING AGENTS THAT MODIFY THE ACTIVITY OF NAPE-PLD OR Abh4
JP5120889B2 (ja) * 2008-06-12 2013-01-16 独立行政法人産業技術総合研究所 ボロンジピロロメタン誘導体及びそれを用いた過酸化脂質測定試薬
CN102288749B (zh) * 2011-07-28 2013-07-31 山东农业大学 敌百虫仿生酶联免疫吸附检测方法
GB201301043D0 (en) * 2013-01-21 2013-03-06 Chronos Therapeutics Ltd Method for assessing cell aging
EP2775302A1 (de) * 2013-03-08 2014-09-10 Assistance Publique - Hôpitaux de Paris Verbindungsträgersysteme für Tests in Nematoden
CN108794518B (zh) * 2018-04-04 2020-06-19 安徽师范大学 一种以bodipy为基本骨架的有机共轭分子材料及其制备方法
CN109799295A (zh) * 2019-01-28 2019-05-24 江南大学 一种用于秀丽隐杆线虫代谢组学分析的样品前处理方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774339A (en) 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
WO1990009096A2 (en) * 1989-02-03 1990-08-23 Cambridge Neuroscience Research, Inc. Method of screening and classifying compounds
US5274113A (en) 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5338854A (en) 1991-02-13 1994-08-16 Molecular Probes, Inc. Fluorescent fatty acids derived from dipyrrometheneboron difluoride dyes
US5583008A (en) * 1993-05-19 1996-12-10 Nemapharm, Inc. Rapid diagnostic procedure for ivermectin resistance
US6342379B1 (en) * 1995-06-07 2002-01-29 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
US5994063A (en) * 1995-06-23 1999-11-30 Metzker; Michael L. Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds for homogenous amplification/detection assays
US5929062A (en) * 1997-06-19 1999-07-27 University Of Western Ontario Oxysterol inhibition of dietary cholesterol uptake
US6114177A (en) * 1997-11-12 2000-09-05 Phytochem Technologies, Inc. Fluorometric assay for measurement of antioxidant activity
CN1285001A (zh) * 1997-12-18 2001-02-21 塞普拉科有限公司 同时鉴定新型生物靶和用于药物开发的引导结构的方法
US6348321B1 (en) * 1998-01-15 2002-02-19 Whitehead Institute For Biomedical Research Methods of identifying agents inhibiting fatty acid transport proteins
GB9827152D0 (en) 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
GB2351151B (en) 1999-04-15 2001-07-25 Devgen Nv Compound Screening Method in Nematode Worms
GB9908677D0 (en) 1999-04-15 1999-06-09 Devgen Nv Compound assay
US6323186B1 (en) * 1999-09-17 2001-11-27 Molecular Probes, Inc. Phosphate-bound polyazaindacene derivatives of nucleotides

Also Published As

Publication number Publication date
AU2001262601A1 (en) 2001-11-26
GB2366615A (en) 2002-03-13
EP1285269A2 (de) 2003-02-26
DE60108746D1 (de) 2005-03-10
WO2001088533A3 (en) 2002-05-16
WO2001088533A2 (en) 2001-11-22
EP1282816A2 (de) 2003-02-12
DE60108746T2 (de) 2006-03-30
EP1285269B1 (de) 2005-02-02
GB0012229D0 (en) 2000-07-12
GB2366615B (en) 2002-07-24
GB0112360D0 (en) 2001-07-11
AU2001264163A1 (en) 2001-11-26
US6703214B2 (en) 2004-03-09
WO2001088532A2 (en) 2001-11-22
WO2001088532A3 (en) 2002-04-04
JP2004524803A (ja) 2004-08-19
JP2003533696A (ja) 2003-11-11
US20020137205A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
DE60126311D1 (de) Verfahren zur 2d-inversion von doppel-laterolog-messungen
DE60216389D1 (de) Verfahren zur zerstörungsfreien Prüfung
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
ATE469219T1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
DE59912512D1 (de) Messanordnung zur Erfassung von Dimensionen von Prüflingen, vorzugsweise von Hohlkörpern, insbesondere von Bohrungen in Werkstücken, sowie Verfahren zur Messung solcher Dimensionen
DE60226797D1 (de) Instrument zum Einbringen von Befestigungselementen für Transplantate
DE60108746D1 (de) Verfahren zur bestimmung der lipid-aufnahme
DE50109692D1 (de) Verfahren zur beurteilung des verschleisses von motoröl
DE60232117D1 (de) Verfahren zur Dickenmessung
ATE347611T1 (de) Automatischer apparat zum messen von wassertoxizität
DE60314955D1 (de) Verfahren zur Inspektion von Dampfturbinen
DE50113292D1 (de) Verfahren zur abreicherung von endotoxinen
DE60335409D1 (de) Verfahren zur bestimmung derpunktdefektverteilung eines siliciumeinkristallstabs
ATE221657T1 (de) Entstörung durch rheumafaktoren
ATE347105T1 (de) Verfahren, assay und kit zur quantifizierung von hiv-proteasehemmer
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE60301283D1 (de) Verfahren zur Bestimmung von Biopolymeren
ATE333521T1 (de) Detektion von vancomycin-resistenten enterococcus-subspezies
DE50115789D1 (de) Verfahren zur verbesserung des regelverhaltens eines abs
DE60141221D1 (de) Verfahren zur genexpressionsanalyse
DE60332076D1 (de) Doppelmessverfahren zur Anzeige des Inhalts von Poststücken
FI20000325A0 (fi) Menetelmä rakenteen rasituksen määrittämiseksi
DE50209215D1 (de) Verfahren zur Dichtigkeitsprüfung von kapazitiven Sensoren
DE10360844B4 (de) Verfahren zum Nachweis und zur Entfernung von Endotoxin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties